Global Oncology Based Molecular Diagnostics Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
The Oncology Based Molecular Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Oncology Based Molecular Diagnostics market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Breast Cancer accounting for % of the Oncology Based Molecular Diagnostics global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While PCR segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Oncology Based Molecular Diagnostics include Abbott Laboratories, Bayer Healthcare, Becton Dickinson, Cepheid, and Dako, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Oncology Based Molecular Diagnostics market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
PCR
Multiplex PCR
In Situ Hybridization
Isothermal Nucleic Acid Amplification Technology (INAAT)
Market segment by Application can be divided into
Breast Cancer
Prostate Cancer
Colorectal Cancer
Cervical Cancer
Other
The key market players for global Oncology Based Molecular Diagnostics market are listed below:
Abbott Laboratories
Bayer Healthcare
Becton Dickinson
Cepheid
Dako
Danaher Corporation
Gen Probe(Hologic)
Roche Diagnostics
Siemens Healthcare
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Oncology Based Molecular Diagnostics product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Oncology Based Molecular Diagnostics, with price, sales, revenue and global market share of Oncology Based Molecular Diagnostics from 2019 to 2022.
Chapter 3, the Oncology Based Molecular Diagnostics competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Oncology Based Molecular Diagnostics breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Oncology Based Molecular Diagnostics market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Oncology Based Molecular Diagnostics.
Chapter 13, 14, and 15, to describe Oncology Based Molecular Diagnostics sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Oncology Based Molecular Diagnostics Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Oncology Based Molecular Diagnostics Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 PCR
1.2.3 Multiplex PCR
1.2.4 In Situ Hybridization
1.2.5 Isothermal Nucleic Acid Amplification Technology (INAAT)
1.3 Market Analysis by Application
1.3.1 Overview: Global Oncology Based Molecular Diagnostics Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Breast Cancer
1.3.3 Prostate Cancer
1.3.4 Colorectal Cancer
1.3.5 Cervical Cancer
1.3.6 Other
1.4 Global Oncology Based Molecular Diagnostics Market Size & Forecast
1.4.1 Global Oncology Based Molecular Diagnostics Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Oncology Based Molecular Diagnostics Sales in Volume (2017-2028)
1.4.3 Global Oncology Based Molecular Diagnostics Price (2017-2028)
1.5 Global Oncology Based Molecular Diagnostics Production Capacity Analysis
1.5.1 Global Oncology Based Molecular Diagnostics Total Production Capacity (2017-2028)
1.5.2 Global Oncology Based Molecular Diagnostics Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Oncology Based Molecular Diagnostics Market Drivers
1.6.2 Oncology Based Molecular Diagnostics Market Restraints
1.6.3 Oncology Based Molecular Diagnostics Trends Analysis
2 Manufacturers Profiles
2.1 Abbott Laboratories
2.1.1 Abbott Laboratories Details
2.1.2 Abbott Laboratories Major Business
2.1.3 Abbott Laboratories Oncology Based Molecular Diagnostics Product and Services
2.1.4 Abbott Laboratories Oncology Based Molecular Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Bayer Healthcare
2.2.1 Bayer Healthcare Details
2.2.2 Bayer Healthcare Major Business
2.2.3 Bayer Healthcare Oncology Based Molecular Diagnostics Product and Services
2.2.4 Bayer Healthcare Oncology Based Molecular Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Becton Dickinson
2.3.1 Becton Dickinson Details
2.3.2 Becton Dickinson Major Business
2.3.3 Becton Dickinson Oncology Based Molecular Diagnostics Product and Services
2.3.4 Becton Dickinson Oncology Based Molecular Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Cepheid
2.4.1 Cepheid Details
2.4.2 Cepheid Major Business
2.4.3 Cepheid Oncology Based Molecular Diagnostics Product and Services
2.4.4 Cepheid Oncology Based Molecular Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Dako
2.5.1 Dako Details
2.5.2 Dako Major Business
2.5.3 Dako Oncology Based Molecular Diagnostics Product and Services
2.5.4 Dako Oncology Based Molecular Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Danaher Corporation
2.6.1 Danaher Corporation Details
2.6.2 Danaher Corporation Major Business
2.6.3 Danaher Corporation Oncology Based Molecular Diagnostics Product and Services
2.6.4 Danaher Corporation Oncology Based Molecular Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Gen Probe(Hologic)
2.7.1 Gen Probe(Hologic) Details
2.7.2 Gen Probe(Hologic) Major Business
2.7.3 Gen Probe(Hologic) Oncology Based Molecular Diagnostics Product and Services
2.7.4 Gen Probe(Hologic) Oncology Based Molecular Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Roche Diagnostics
2.8.1 Roche Diagnostics Details
2.8.2 Roche Diagnostics Major Business
2.8.3 Roche Diagnostics Oncology Based Molecular Diagnostics Product and Services
2.8.4 Roche Diagnostics Oncology Based Molecular Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Siemens Healthcare
2.9.1 Siemens Healthcare Details
2.9.2 Siemens Healthcare Major Business
2.9.3 Siemens Healthcare Oncology Based Molecular Diagnostics Product and Services
2.9.4 Siemens Healthcare Oncology Based Molecular Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Oncology Based Molecular Diagnostics Breakdown Data by Manufacturer
3.1 Global Oncology Based Molecular Diagnostics Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Oncology Based Molecular Diagnostics Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Oncology Based Molecular Diagnostics
3.4 Market Concentration Rate
3.4.1 Top 3 Oncology Based Molecular Diagnostics Manufacturer Market Share in 2021
3.4.2 Top 6 Oncology Based Molecular Diagnostics Manufacturer Market Share in 2021
3.5 Global Oncology Based Molecular Diagnostics Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Oncology Based Molecular Diagnostics Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Oncology Based Molecular Diagnostics Market Size by Region
4.1.1 Global Oncology Based Molecular Diagnostics Sales in Volume by Region (2017-2028)
4.1.2 Global Oncology Based Molecular Diagnostics Revenue by Region (2017-2028)
4.2 North America Oncology Based Molecular Diagnostics Revenue (2017-2028)
4.3 Europe Oncology Based Molecular Diagnostics Revenue (2017-2028)
4.4 Asia-Pacific Oncology Based Molecular Diagnostics Revenue (2017-2028)
4.5 South America Oncology Based Molecular Diagnostics Revenue (2017-2028)
4.6 Middle East and Africa Oncology Based Molecular Diagnostics Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Oncology Based Molecular Diagnostics Sales in Volume by Type (2017-2028)
5.2 Global Oncology Based Molecular Diagnostics Revenue by Type (2017-2028)
5.3 Global Oncology Based Molecular Diagnostics Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Oncology Based Molecular Diagnostics Sales in Volume by Application (2017-2028)
6.2 Global Oncology Based Molecular Diagnostics Revenue by Application (2017-2028)
6.3 Global Oncology Based Molecular Diagnostics Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Oncology Based Molecular Diagnostics Sales by Type (2017-2028)
7.2 North America Oncology Based Molecular Diagnostics Sales by Application (2017-2028)
7.3 North America Oncology Based Molecular Diagnostics Market Size by Country
7.3.1 North America Oncology Based Molecular Diagnostics Sales in Volume by Country (2017-2028)
7.3.2 North America Oncology Based Molecular Diagnostics Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Oncology Based Molecular Diagnostics Sales by Type (2017-2028)
8.2 Europe Oncology Based Molecular Diagnostics Sales by Application (2017-2028)
8.3 Europe Oncology Based Molecular Diagnostics Market Size by Country
8.3.1 Europe Oncology Based Molecular Diagnostics Sales in Volume by Country (2017-2028)
8.3.2 Europe Oncology Based Molecular Diagnostics Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Oncology Based Molecular Diagnostics Sales by Type (2017-2028)
9.2 Asia-Pacific Oncology Based Molecular Diagnostics Sales by Application (2017-2028)
9.3 Asia-Pacific Oncology Based Molecular Diagnostics Market Size by Region
9.3.1 Asia-Pacific Oncology Based Molecular Diagnostics Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Oncology Based Molecular Diagnostics Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Oncology Based Molecular Diagnostics Sales by Type (2017-2028)
10.2 South America Oncology Based Molecular Diagnostics Sales by Application (2017-2028)
10.3 South America Oncology Based Molecular Diagnostics Market Size by Country
10.3.1 South America Oncology Based Molecular Diagnostics Sales in Volume by Country (2017-2028)
10.3.2 South America Oncology Based Molecular Diagnostics Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Oncology Based Molecular Diagnostics Sales by Type (2017-2028)
11.2 Middle East & Africa Oncology Based Molecular Diagnostics Sales by Application (2017-2028)
11.3 Middle East & Africa Oncology Based Molecular Diagnostics Market Size by Country
11.3.1 Middle East & Africa Oncology Based Molecular Diagnostics Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Oncology Based Molecular Diagnostics Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Oncology Based Molecular Diagnostics and Key Manufacturers
12.2 Manufacturing Costs Percentage of Oncology Based Molecular Diagnostics
12.3 Oncology Based Molecular Diagnostics Production Process
12.4 Oncology Based Molecular Diagnostics Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Oncology Based Molecular Diagnostics Typical Distributors
13.3 Oncology Based Molecular Diagnostics Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of Tables
Table 1. Global Oncology Based Molecular Diagnostics Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Oncology Based Molecular Diagnostics Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table 4. Abbott Laboratories Major Business
Table 5. Abbott Laboratories Oncology Based Molecular Diagnostics Product and Services
Table 6. Abbott Laboratories Oncology Based Molecular Diagnostics Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Bayer Healthcare Basic Information, Manufacturing Base and Competitors
Table 8. Bayer Healthcare Major Business
Table 9. Bayer Healthcare Oncology Based Molecular Diagnostics Product and Services
Table 10. Bayer Healthcare Oncology Based Molecular Diagnostics Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Becton Dickinson Basic Information, Manufacturing Base and Competitors
Table 12. Becton Dickinson Major Business
Table 13. Becton Dickinson Oncology Based Molecular Diagnostics Product and Services
Table 14. Becton Dickinson Oncology Based Molecular Diagnostics Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Cepheid Basic Information, Manufacturing Base and Competitors
Table 16. Cepheid Major Business
Table 17. Cepheid Oncology Based Molecular Diagnostics Product and Services
Table 18. Cepheid Oncology Based Molecular Diagnostics Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Dako Basic Information, Manufacturing Base and Competitors
Table 20. Dako Major Business
Table 21. Dako Oncology Based Molecular Diagnostics Product and Services
Table 22. Dako Oncology Based Molecular Diagnostics Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Danaher Corporation Basic Information, Manufacturing Base and Competitors
Table 24. Danaher Corporation Major Business
Table 25. Danaher Corporation Oncology Based Molecular Diagnostics Product and Services
Table 26. Danaher Corporation Oncology Based Molecular Diagnostics Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Gen Probe(Hologic) Basic Information, Manufacturing Base and Competitors
Table 28. Gen Probe(Hologic) Major Business
Table 29. Gen Probe(Hologic) Oncology Based Molecular Diagnostics Product and Services
Table 30. Gen Probe(Hologic) Oncology Based Molecular Diagnostics Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Roche Diagnostics Basic Information, Manufacturing Base and Competitors
Table 32. Roche Diagnostics Major Business
Table 33. Roche Diagnostics Oncology Based Molecular Diagnostics Product and Services
Table 34. Roche Diagnostics Oncology Based Molecular Diagnostics Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Siemens Healthcare Basic Information, Manufacturing Base and Competitors
Table 36. Siemens Healthcare Major Business
Table 37. Siemens Healthcare Oncology Based Molecular Diagnostics Product and Services
Table 38. Siemens Healthcare Oncology Based Molecular Diagnostics Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Global Oncology Based Molecular Diagnostics Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 40. Global Oncology Based Molecular Diagnostics Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 41. Market Position of Manufacturers in Oncology Based Molecular Diagnostics, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 42. Global Oncology Based Molecular Diagnostics Production Capacity by Company, (K Units): 2020 VS 2021
Table 43. Head Office and Oncology Based Molecular Diagnostics Production Site of Key Manufacturer
Table 44. Oncology Based Molecular Diagnostics New Entrant and Capacity Expansion Plans
Table 45. Oncology Based Molecular Diagnostics Mergers & Acquisitions in the Past Five Years
Table 46. Global Oncology Based Molecular Diagnostics Sales by Region (2017-2022) & (K Units)
Table 47. Global Oncology Based Molecular Diagnostics Sales by Region (2023-2028) & (K Units)
Table 48. Global Oncology Based Molecular Diagnostics Revenue by Region (2017-2022) & (USD Million)
Table 49. Global Oncology Based Molecular Diagnostics Revenue by Region (2023-2028) & (USD Million)
Table 50. Global Oncology Based Molecular Diagnostics Sales by Type (2017-2022) & (K Units)
Table 51. Global Oncology Based Molecular Diagnostics Sales by Type (2023-2028) & (K Units)
Table 52. Global Oncology Based Molecular Diagnostics Revenue by Type (2017-2022) & (USD Million)
Table 53. Global Oncology Based Molecular Diagnostics Revenue by Type (2023-2028) & (USD Million)
Table 54. Global Oncology Based Molecular Diagnostics Price by Type (2017-2022) & (USD/Unit)
Table 55. Global Oncology Based Molecular Diagnostics Price by Type (2023-2028) & (USD/Unit)
Table 56. Global Oncology Based Molecular Diagnostics Sales by Application (2017-2022) & (K Units)
Table 57. Global Oncology Based Molecular Diagnostics Sales by Application (2023-2028) & (K Units)
Table 58. Global Oncology Based Molecular Diagnostics Revenue by Application (2017-2022) & (USD Million)
Table 59. Global Oncology Based Molecular Diagnostics Revenue by Application (2023-2028) & (USD Million)
Table 60. Global Oncology Based Molecular Diagnostics Price by Application (2017-2022) & (USD/Unit)
Table 61. Global Oncology Based Molecular Diagnostics Price by Application (2023-2028) & (USD/Unit)
Table 62. North America Oncology Based Molecular Diagnostics Sales by Country (2017-2022) & (K Units)
Table 63. North America Oncology Based Molecular Diagnostics Sales by Country (2023-2028) & (K Units)
Table 64. North America Oncology Based Molecular Diagnostics Revenue by Country (2017-2022) & (USD Million)
Table 65. North America Oncology Based Molecular Diagnostics Revenue by Country (2023-2028) & (USD Million)
Table 66. North America Oncology Based Molecular Diagnostics Sales by Type (2017-2022) & (K Units)
Table 67. North America Oncology Based Molecular Diagnostics Sales by Type (2023-2028) & (K Units)
Table 68. North America Oncology Based Molecular Diagnostics Sales by Application (2017-2022) & (K Units)
Table 69. North America Oncology Based Molecular Diagnostics Sales by Application (2023-2028) & (K Units)
Table 70. Europe Oncology Based Molecular Diagnostics Sales by Country (2017-2022) & (K Units)
Table 71. Europe Oncology Based Molecular Diagnostics Sales by Country (2023-2028) & (K Units)
Table 72. Europe Oncology Based Molecular Diagnostics Revenue by Country (2017-2022) & (USD Million)
Table 73. Europe Oncology Based Molecular Diagnostics Revenue by Country (2023-2028) & (USD Million)
Table 74. Europe Oncology Based Molecular Diagnostics Sales by Type (2017-2022) & (K Units)
Table 75. Europe Oncology Based Molecular Diagnostics Sales by Type (2023-2028) & (K Units)
Table 76. Europe Oncology Based Molecular Diagnostics Sales by Application (2017-2022) & (K Units)
Table 77. Europe Oncology Based Molecular Diagnostics Sales by Application (2023-2028) & (K Units)
Table 78. Asia-Pacific Oncology Based Molecular Diagnostics Sales by Region (2017-2022) & (K Units)
Table 79. Asia-Pacific Oncology Based Molecular Diagnostics Sales by Region (2023-2028) & (K Units)
Table 80. Asia-Pacific Oncology Based Molecular Diagnostics Revenue by Region (2017-2022) & (USD Million)
Table 81. Asia-Pacific Oncology Based Molecular Diagnostics Revenue by Region (2023-2028) & (USD Million)
Table 82. Asia-Pacific Oncology Based Molecular Diagnostics Sales by Type (2017-2022) & (K Units)
Table 83. Asia-Pacific Oncology Based Molecular Diagnostics Sales by Type (2023-2028) & (K Units)
Table 84. Asia-Pacific Oncology Based Molecular Diagnostics Sales by Application (2017-2022) & (K Units)
Table 85. Asia-Pacific Oncology Based Molecular Diagnostics Sales by Application (2023-2028) & (K Units)
Table 86. South America Oncology Based Molecular Diagnostics Sales by Country (2017-2022) & (K Units)
Table 87. South America Oncology Based Molecular Diagnostics Sales by Country (2023-2028) & (K Units)
Table 88. South America Oncology Based Molecular Diagnostics Revenue by Country (2017-2022) & (USD Million)
Table 89. South America Oncology Based Molecular Diagnostics Revenue by Country (2023-2028) & (USD Million)
Table 90. South America Oncology Based Molecular Diagnostics Sales by Type (2017-2022) & (K Units)
Table 91. South America Oncology Based Molecular Diagnostics Sales by Type (2023-2028) & (K Units)
Table 92. South America Oncology Based Molecular Diagnostics Sales by Application (2017-2022) & (K Units)
Table 93. South America Oncology Based Molecular Diagnostics Sales by Application (2023-2028) & (K Units)
Table 94. Middle East & Africa Oncology Based Molecular Diagnostics Sales by Region (2017-2022) & (K Units)
Table 95. Middle East & Africa Oncology Based Molecular Diagnostics Sales by Region (2023-2028) & (K Units)
Table 96. Middle East & Africa Oncology Based Molecular Diagnostics Revenue by Region (2017-2022) & (USD Million)
Table 97. Middle East & Africa Oncology Based Molecular Diagnostics Revenue by Region (2023-2028) & (USD Million)
Table 98. Middle East & Africa Oncology Based Molecular Diagnostics Sales by Type (2017-2022) & (K Units)
Table 99. Middle East & Africa Oncology Based Molecular Diagnostics Sales by Type (2023-2028) & (K Units)
Table 100. Middle East & Africa Oncology Based Molecular Diagnostics Sales by Application (2017-2022) & (K Units)
Table 101. Middle East & Africa Oncology Based Molecular Diagnostics Sales by Application (2023-2028) & (K Units)
Table 102. Oncology Based Molecular Diagnostics Raw Material
Table 103. Key Manufacturers of Oncology Based Molecular Diagnostics Raw Materials
Table 104. Direct Channel Pros & Cons
Table 105. Indirect Channel Pros & Cons
Table 106. Oncology Based Molecular Diagnostics Typical Distributors
Table 107. Oncology Based Molecular Diagnostics Typical Customers
List of Figures
Figure 1. Oncology Based Molecular Diagnostics Picture
Figure 2. Global Oncology Based Molecular Diagnostics Revenue Market Share by Type in 2021
Figure 3. PCR
Figure 4. Multiplex PCR
Figure 5. In Situ Hybridization
Figure 6. Isothermal Nucleic Acid Amplification Technology (INAAT)
Figure 7. Global Oncology Based Molecular Diagnostics Revenue Market Share by Application in 2021
Figure 8. Breast Cancer
Figure 9. Prostate Cancer
Figure 10. Colorectal Cancer
Figure 11. Cervical Cancer
Figure 12. Other
Figure 13. Global Oncology Based Molecular Diagnostics Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 14. Global Oncology Based Molecular Diagnostics Revenue and Forecast (2017-2028) & (USD Million)
Figure 15. Global Oncology Based Molecular Diagnostics Sales (2017-2028) & (K Units)
Figure 16. Global Oncology Based Molecular Diagnostics Price (2017-2028) & (USD/Unit)
Figure 17. Global Oncology Based Molecular Diagnostics Production Capacity (2017-2028) & (K Units)
Figure 18. Global Oncology Based Molecular Diagnostics Production Capacity by Geographic Region: 2022 VS 2028
Figure 19. Oncology Based Molecular Diagnostics Market Drivers
Figure 20. Oncology Based Molecular Diagnostics Market Restraints
Figure 21. Oncology Based Molecular Diagnostics Market Trends
Figure 22. Global Oncology Based Molecular Diagnostics Sales Market Share by Manufacturer in 2021
Figure 23. Global Oncology Based Molecular Diagnostics Revenue Market Share by Manufacturer in 2021
Figure 24. Oncology Based Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 25. Top 3 Oncology Based Molecular Diagnostics Manufacturer (Revenue) Market Share in 2021
Figure 26. Top 6 Oncology Based Molecular Diagnostics Manufacturer (Revenue) Market Share in 2021
Figure 27. Global Oncology Based Molecular Diagnostics Sales Market Share by Region (2017-2028)
Figure 28. Global Oncology Based Molecular Diagnostics Revenue Market Share by Region (2017-2028)
Figure 29. North America Oncology Based Molecular Diagnostics Revenue (2017-2028) & (USD Million)
Figure 30. Europe Oncology Based Molecular Diagnostics Revenue (2017-2028) & (USD Million)
Figure 31. Asia-Pacific Oncology Based Molecular Diagnostics Revenue (2017-2028) & (USD Million)
Figure 32. South America Oncology Based Molecular Diagnostics Revenue (2017-2028) & (USD Million)
Figure 33. Middle East & Africa Oncology Based Molecular Diagnostics Revenue (2017-2028) & (USD Million)
Figure 34. Global Oncology Based Molecular Diagnostics Sales Market Share by Type (2017-2028)
Figure 35. Global Oncology Based Molecular Diagnostics Revenue Market Share by Type (2017-2028)
Figure 36. Global Oncology Based Molecular Diagnostics Price by Type (2017-2028) & (USD/Unit)
Figure 37. Global Oncology Based Molecular Diagnostics Sales Market Share by Application (2017-2028)
Figure 38. Global Oncology Based Molecular Diagnostics Revenue Market Share by Application (2017-2028)
Figure 39. Global Oncology Based Molecular Diagnostics Price by Application (2017-2028) & (USD/Unit)
Figure 40. North America Oncology Based Molecular Diagnostics Sales Market Share by Type (2017-2028)
Figure 41. North America Oncology Based Molecular Diagnostics Sales Market Share by Application (2017-2028)
Figure 42. North America Oncology Based Molecular Diagnostics Sales Market Share by Country (2017-2028)
Figure 43. North America Oncology Based Molecular Diagnostics Revenue Market Share by Country (2017-2028)
Figure 44. United States Oncology Based Molecular Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Canada Oncology Based Molecular Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Mexico Oncology Based Molecular Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Europe Oncology Based Molecular Diagnostics Sales Market Share by Type (2017-2028)
Figure 48. Europe Oncology Based Molecular Diagnostics Sales Market Share by Application (2017-2028)
Figure 49. Europe Oncology Based Molecular Diagnostics Sales Market Share by Country (2017-2028)
Figure 50. Europe Oncology Based Molecular Diagnostics Revenue Market Share by Country (2017-2028)
Figure 51. Germany Oncology Based Molecular Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. France Oncology Based Molecular Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. United Kingdom Oncology Based Molecular Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Russia Oncology Based Molecular Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Italy Oncology Based Molecular Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Asia-Pacific Oncology Based Molecular Diagnostics Sales Market Share by Region (2017-2028)
Figure 57. Asia-Pacific Oncology Based Molecular Diagnostics Sales Market Share by Application (2017-2028)
Figure 58. Asia-Pacific Oncology Based Molecular Diagnostics Sales Market Share by Region (2017-2028)
Figure 59. Asia-Pacific Oncology Based Molecular Diagnostics Revenue Market Share by Region (2017-2028)
Figure 60. China Oncology Based Molecular Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Japan Oncology Based Molecular Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Korea Oncology Based Molecular Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. India Oncology Based Molecular Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Southeast Asia Oncology Based Molecular Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Australia Oncology Based Molecular Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. South America Oncology Based Molecular Diagnostics Sales Market Share by Type (2017-2028)
Figure 67. South America Oncology Based Molecular Diagnostics Sales Market Share by Application (2017-2028)
Figure 68. South America Oncology Based Molecular Diagnostics Sales Market Share by Country (2017-2028)
Figure 69. South America Oncology Based Molecular Diagnostics Revenue Market Share by Country (2017-2028)
Figure 70. Brazil Oncology Based Molecular Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Argentina Oncology Based Molecular Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Middle East & Africa Oncology Based Molecular Diagnostics Sales Market Share by Type (2017-2028)
Figure 73. Middle East & Africa Oncology Based Molecular Diagnostics Sales Market Share by Application (2017-2028)
Figure 74. Middle East & Africa Oncology Based Molecular Diagnostics Sales Market Share by Region (2017-2028)
Figure 75. Middle East & Africa Oncology Based Molecular Diagnostics Revenue Market Share by Region (2017-2028)
Figure 76. Turkey Oncology Based Molecular Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Egypt Oncology Based Molecular Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Saudi Arabia Oncology Based Molecular Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. South Africa Oncology Based Molecular Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. Manufacturing Cost Structure Analysis of Oncology Based Molecular Diagnostics in 2021
Figure 81. Manufacturing Process Analysis of Oncology Based Molecular Diagnostics
Figure 82. Oncology Based Molecular Diagnostics Industrial Chain
Figure 83. Sales Channel: Direct Channel vs Indirect Channel
Figure 84. Methodology
Figure 85. Research Process and Data Source
